Symproic

Product manufactured by Purdue Pharma Lp

Application Nr Approved Date Route Status External Links
NDA208854 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Symproic Is Indicated For The Treatment Of Opioid-Induced Constipation (Oic) In Adult Patients With Chronic Non-Cancer Pain, Including Patients With Chronic Pain Related To Prior Cancer Or Its Treatment Who Do Not Require Frequent (E.g., Weekly) Opioid Dosage Escalation. Symproic Is An Opioid Antagonist Indicated For The Treatment Of Opioid-Induced Constipation (Oic) In Adult Patients With Chronic Non-Cancer Pain, Including Patients With Chronic Pain Related To Prior Cancer Or Its Treatment Who Do Not Require Frequent (E.g., Weekly) Opioid Dosage Escalation ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Naldemedine Tosylate NALDEMEDINE TOSYLATE ZINC100378061

Comments